Consulter en ligne

Suggestions

Du même auteur

Unresectable hepatocellular carcinoma at dawn of immunotherapy era: real-world data from the French prospective CHIEF cohort

Archive ouverte | Nguyen-Khac, Eric | CCSD

International audience. Background and objectives Hepatocellular carcinoma epidemiological data are limited in France. The Epidemio Liver Immunotherapy Tecentriq outcome research (ELITor) retrospective study, based ...

Unresectable HCC patients disposal in the new era of immunotherapy from the elitor study based on the French chief cohort

Archive ouverte | Nguyen-Khac, Eric | CCSD

International audience

Cabozantinib (CABO) tolerance and efficacy for patients with advanced hepatocellular carcinoma (HCC) after failure of sorafenib (SOR) in a French population: CLERANCE, a phase 4 trial

Archive ouverte | Merle, Philippe | CCSD

Meeting abstract "Genitourinary cancers symposium", San Francisco, CA, January 19-21, 2023. International audience. Background: CABO is approved in second (2L) or third line (3L) systemic therapy for pts with advanc...

Chargement des enrichissements...